According to MarketsandMarketstm, the Biomarkers Market is projected to grow from about USD 67.95 billion in 2026 to USD 112.10 billion by 2031, at a CAGR of 10.5%. Browse 690 market data Tables and ...
Colorectal cancer (CRC) remains one of the most heterogeneous malignancies, with substantial variability in molecular ...
As genetic testing becomes increasingly important in modern healthcare, cytogenetics is emerging as a promising career for ...
DelveInsight's DNA Diagnostics Market Insights report provides the current and forecast market analysis, individual leading DNA diagnostics companies' market shares, challenges, DNA diagnostics market ...
A systematic review and meta-analysis of 28 cohort-based studies found a weak but statistically significant association ...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...
Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payload platform with potential impact ...
Researchers from The University of Texas MD Anderson Cancer Center demonstrated that an artificial intelligence (AI)-based ...
Cancer immunotherapy drugs known as immune checkpoint inhibitors (ICIs) can be miracle drugs for cancer patients, curing some and turning deadly disease into a manageable chronic condition in others.
Potentially fraudulent papers often cite each other and could be inflating the impact factor of journals in which they are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results